Skip to main content

Advertisement

ADVERTISEMENT

News

News
10/31/2022
FLAGSTAFF, Ariz. — W. L. Gore & Associates (Gore) announced the first implants of its investigational GORE® VIAFORT Vascular Stent as part of the recently initiated GORE VIAFORT Device Pivotal Clinical Study, (i.e.,...
FLAGSTAFF, Ariz. — W. L. Gore & Associates (Gore) announced the first implants of its investigational GORE® VIAFORT Vascular Stent as part of the recently initiated GORE VIAFORT Device Pivotal Clinical Study, (i.e.,...
FLAGSTAFF, Ariz. — W. L....
10/31/2022
Cath Lab Digest

Advertisement

News
10/27/2022
Transit Scientific, developing medical devices to treat calcified cardiovascular disease, dilate stenosed intimal hyperplasia, and access, cross, & deliver to distal vessels, announced today the XO RX 2.2F and XO RX 3.8F Platform received FDA...
Transit Scientific, developing medical devices to treat calcified cardiovascular disease, dilate stenosed intimal hyperplasia, and access, cross, & deliver to distal vessels, announced today the XO RX 2.2F and XO RX 3.8F Platform received FDA...
Transit Scientific, developing...
10/27/2022
Cath Lab Digest
News
10/26/2022
Clinical study evaluates treatment for endovascular aortic arch repair CLEVELAND – Thousands of people have new hope for treatment of thoracic aortic arch disease and University Hospitals (UH) Harrington Heart & Vascular Institute is...
Clinical study evaluates treatment for endovascular aortic arch repair CLEVELAND – Thousands of people have new hope for treatment of thoracic aortic arch disease and University Hospitals (UH) Harrington Heart & Vascular Institute is...
Clinical study evaluates...
10/26/2022
Vascular Disease Management
News
10/25/2022
Philips aims to help the international community advance stroke care with partners to connect information, technologies and people across the stroke care pathway, enabling care teams to work quickly and act decisively for stroke treatment.
Philips aims to help the international community advance stroke care with partners to connect information, technologies and people across the stroke care pathway, enabling care teams to work quickly and act decisively for stroke treatment.
Philips aims to help the...
10/25/2022
Vascular Disease Management

Advertisement

News
10/20/2022
The procedure took place in the Cardiac Catheterization Lab and was just the fourth-in-human use for the device, which is made by ŌNŌCOR and received Food and Drug Administration clearance in May. The team also used endovascular snares and...
The procedure took place in the Cardiac Catheterization Lab and was just the fourth-in-human use for the device, which is made by ŌNŌCOR and received Food and Drug Administration clearance in May. The team also used endovascular snares and...
The procedure took place in...
10/20/2022
Cath Lab Digest
News
10/19/2022
The trial met its primary efficacy outcome measure, demonstrating a statistically significant and clinically meaningful improvement in 6-minute walk distance (6MWD, which measures how far patients can walk in 6 minutes) from baseline at 24...
The trial met its primary efficacy outcome measure, demonstrating a statistically significant and clinically meaningful improvement in 6-minute walk distance (6MWD, which measures how far patients can walk in 6 minutes) from baseline at 24...
The trial met its primary...
10/19/2022
Cath Lab Digest
News
10/19/2022
An analysis of race-related patient safety reports by ECRI, the nation’s largest nonprofit patient safety organization, shows that both patients and healthcare providers are frequently on the receiving end of inappropriate comments about race.
An analysis of race-related patient safety reports by ECRI, the nation’s largest nonprofit patient safety organization, shows that both patients and healthcare providers are frequently on the receiving end of inappropriate comments about race.
An analysis of race-related...
10/19/2022
Cath Lab Digest

Advertisement

News
10/18/2022
By acquiring MedAlliance, Cordis has the potential to serve two million patients globally by 2027 with the SELUTION SLR™ (Sustained Limus Release) drug-eluting balloon.
By acquiring MedAlliance, Cordis has the potential to serve two million patients globally by 2027 with the SELUTION SLR™ (Sustained Limus Release) drug-eluting balloon.
By acquiring MedAlliance, Cordis...
10/18/2022
Cath Lab Digest
News
10/17/2022
Cardiovascular Systems, Inc. (CSI) announced today the full market release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems (2.00 Max Crown).
Cardiovascular Systems, Inc. (CSI) announced today the full market release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems (2.00 Max Crown).
Cardiovascular Systems, Inc....
10/17/2022
Cath Lab Digest
News
10/14/2022
The study enrolled subjects across the spectrum of deep venous disease, including those with post-thrombotic syndrome (PTS), non-thrombotic iliac vein lesions (NIVL), and those who presented with an acute deep vein thrombosis (aDVT).
The study enrolled subjects across the spectrum of deep venous disease, including those with post-thrombotic syndrome (PTS), non-thrombotic iliac vein lesions (NIVL), and those who presented with an acute deep vein thrombosis (aDVT).
The study enrolled subjects...
10/14/2022
Cath Lab Digest

Advertisement

Advertisement